Healthcare -
Biotechnology - NASDAQ - US
$ 17.78
-3.94 %
$ 545 M
Market Cap
-3.47
P/E
ANAB - REVENUE
Revenue ANAB - AnaptysBio, Inc.
91.3 M
LAST VALUE
197.88%
2 YEAR CAGR
62.73%
5 YEAR CAGR
19.14%
10 YEAR CAGR